Clinical Significance of Tumor-Infiltrating Lymphocytes in Lung Neoplasms Enrico Ruffini, MD, Sofia Asioli, MD, Pier Luigi Filosso, MD, Paraskevas Lyberis,

Slides:

Advertisements

Similar presentations

Jeffrey L. Port, MD, Robert J. Korst, MD, Paul C. Lee, MD, Amanda L

Advertisements

Definitive or Preoperative Chemoradiation Therapy for Esophageal Cancer: Patterns of Care and Survival Outcomes Meng S. Shao, MD, Andrew T. Wong, MD,

Thomas J. Birdas, MD, Richard P. M

Melanie Subramanian, MD, Timothy McMurry, PhD, Bryan F

Rodrigo A. S. Sardenberg, MD, Clovis Pinto, MD, Cynthia A

Collision Tumor of Esophagus: Report of Three Cases

Joshua E. Rosen, BASc, Hari B

Tumor Necrosis as a Prognostic Factor for Stage IA Non-Small Cell Lung Cancer Seong Yong Park, MD, Hyun-Sung Lee, MD, PhD, Hee-Jin Jang, MD, Geon Kook.

Lisa M. Brown, MD, MAS, David T. Cooke, MD, Elizabeth A. David, MD

Prognostic Factors Associated With Interventional Bronchoscopy in Lung Cancer Nicolas Guibert, MD, Julien Mazieres, MD, PhD, Benoît Lepage, MD, Gavin.

Morbidity, Survival, and Site of Recurrence After Mediastinal Lymph-Node Dissection Versus Systematic Sampling After Complete Resection for Non-Small.

Benjamin E. Lee, MD, Mark Shapiro, MD, John R. Rutledge, MAS, Robert J

Video-Assisted Thoracic Surgery Lobectomy: Experience With 1,100 Cases

David T. Cooke, MD, Danh V. Nguyen, PhD, Ying Yang, MS, Steven L

Lymph Node Evaluation Achieved by Open Lobectomy Compared With Thoracoscopic Lobectomy for N0 Lung Cancer Robert E. Merritt, MD, Chuong D. Hoang, MD,

Survival After Resection for Metastatic Testicular Nonseminomatous Germ Cell Cancer to the Lung or Mediastinum Kenneth A. Kesler, MD, Laura E. Kruter,

Michelle C. Ellis, MD, Brian S. Diggs, PhD, John T. Vetto, MD, Paul H

Expression of Bone Morphogenetic Proteins in Human Lung Carcinomas

Philip W. Smith, MD, Hongkun Wang, PhD, Leo M. Gazoni, MD, K

Combined Resection of Superior Vena Cava for Lung Carcinoma: Prognostic Significance of Patterns of Superior Vena Cava Invasion Kenji Suzuki, MD, Hisao.

Tracheostomy After Cardiac Operations: In-Hospital and Long-Term Survival Andrea Ballotta, MD, Hassan Kandil, MD, Tommaso Generali, MD, Lorenzo Menicanti,

Intrathoracic splenosis: A case report and an update of invasive and noninvasive diagnostic techniques Enrico Ruffini, MD, Sofia Asioli, MD, Pier Luigi.

Asad A. Shah, MD, Mathias Worni, MD, MHS, Christopher R

Thomas J. Birdas, MD, Richard P. M

Who Do You Say You Are? The Annals of Thoracic Surgery

Surgical Considerations for the Management and Resection of Esophageal Gastrointestinal Stromal Tumors Matthew G. Blum, MD, Karl Y. Bilimoria, MD, Jeffrey.

Congenital Absence of Bilateral Common Carotid Arteries

Quality Measures in Clinical Stage I Non-Small Cell Lung Cancer: Improved Performance Is Associated With Improved Survival Pamela Samson, MD, MPHS, Traves.

Characteristics Associated With the Use of Nonanatomic Resections Among Medicare Patients Undergoing Resections of Early-Stage Lung Cancer Anthony W.

Influence of Cigarette Smoking on Survival and Tumor Invasiveness in Clinical Stage IA Lung Adenocarcinoma Ryo Maeda, MD, Junji Yoshida, MD, Genichiro.

Bilobectomy for Lung Cancer: Analysis of Indications, Postoperative Results, and Long- Term Outcomes Domenico Galetta, MD, PhD, Piergiorgio Solli, MD,

Use of Amiodarone After Major Lung Resection

Neuroendocrine tumors of the lung and octreotide scintigraphy

Spontaneous pneumomediastinum: A rare complication of anorexia nervosa

Kuthan Kavakli, MD, Deniz Dogan, MD, Sedat Gurkok

Abel Gómez-Caro, MD, Pedro Arguis, MD The Annals of Thoracic Surgery

Smoking Status as a Prognostic Factor in Patients with Stage I Pulmonary Adenocarcinoma Ichiro Yoshino, MD, PhD, Daigo Kawano, MD, Taro Oba, MD, Koji.

Recurrence and Survival After Segmentectomy in Patients With Prior Lung Resection for Early-Stage Non-Small Cell Lung Cancer Lisa M. Brown, MD, Brian.

Differences in Patterns of Recurrence in Early-Stage Versus Locally Advanced Non- Small Cell Lung Cancer Feiran Lou, MD, MS, Camelia S. Sima, MD, MS,

Predictors of Long-Term Survival After Resection of Esophageal Carcinoma With Nonregional Nodal Metastases Paul C. Lee, MD, Jeffrey L. Port, MD, Subroto.

Surgical Therapy for Bilateral Multiple Primary Lung Cancer

Pulmonary Resection for Lung Cancer in Octogenarians

Significance of the Presence of Microscopic Vascular Invasion After Complete Resection of Stage I–II pT1-T2N0 Non-small Cell Lung Cancer and Its Relation.

High Expression of p300 Has an Unfavorable Impact on Survival in Resectable Esophageal Squamous Cell Carcinoma Yong Li, MD, Hao-Xian Yang, MD, Rong-Zhen.

Selective Mediastinal Lymphadenectomy for Clinico-Surgical Stage I Non–Small Cell Lung Cancer Morihito Okada, MD, PhD, Toshihiko Sakamoto, MD, PhD, Tsuyoshi.

Clinicopathologic Features of Submucosal Esophageal Squamous Cell Carcinoma Manabu Emi, MD, PhD, Jun Hihara, MD, PhD, Yoichi Hamai, MD, PhD, Takaoki Furukawa,

Radiofrequency Ablation for Stage I Non-Small Cell Lung Cancer: Management of Locoregional Recurrence Michael Lanuti, MD, Amita Sharma, MD, Henning Willers,

Clinicopathologic Features and Computed Tomographic Findings of 52 Surgically Resected Adenosquamous Carcinomas of the Lung Yukio Watanabe, MD, Koji.

Editorial Board, January 2010

Daily Chest Roentgenograms Are Unnecessary in Nonhypoxic Patients Who Have Undergone Pulmonary Resection by Thoracotomy Robert James Cerfolio, MD, Ayesha.

Completely Thrombosed Tricuspid Pouch Mimicking a Cardiac Tumor

Subcategorization of Resectable Non-Small Cell Lung Cancer Involving Neighboring Structures Noriaki Sakakura, MD, Shoichi Mori, MD, Futoshi Ishiguro,

Margin Distance Does Not Influence Recurrence and Survival After Wedge Resection for Lung Cancer Giulio Maurizi, MD, Antonio D’Andrilli, MD, Anna Maria.

Predictors of Survival After Operation Among Patients With Large Cell Neuroendocrine Carcinoma of the Lung Florian Eichhorn, MD, Hendrik Dienemann, MD,

Shared Decision Making and Effective Risk Communication in the High-Risk Patient With Operable Stage I Non-Small Cell Lung Cancer Pamela Samson, MD,

Daniel A. Anaya, MD, Mujun Yu, MD, Riyad Karmy-Jones, MD

Advanced Stage Thymomas and Thymic Carcinomas: Results of Multimodality Treatments Marco Lucchi, MD, Marcello Carlo Ambrogi, MD, Leonardo Duranti, MD,

Resected Synchronous Primary Malignant Lung Tumors: A Population-Based Study Hans Rostad, MD, PhD, Trond-Eirik Strand, MD, Anne Naalsund, MD, Jarle Norstein,

Digital Drainage System Reduces Hospitalization After Video-Assisted Thoracoscopic Surgery Lung Resection Daniel L. Miller, MD, Gerald A. Helms, MD,

Neal S Goldstein, MD The Annals of Thoracic Surgery

Hemoptysis caused by an endobronchial lipoma

Effect of Formalin Fixation on Tumor Size Determination in Stage I Non-Small Cell Lung Cancer Po-Kuei Hsu, MD, Hsu-Chih Huang, MD, Chih-Cheng Hsieh,

Mediastinal Paragangliomas: The Mayo Clinic Experience

Clinical Outcome After Pulmonary Resection for Lung Cancer Patients on Hemodialysis Toshiro Obuchi, MD, Wakako Hamanaka, MD, Yasuhiro Yoshida, MD, Jun.

Survival and Outcomes of Pulmonary Resection for Non-Small Cell Lung Cancer in the Elderly: A Nested Case-Control Study Robert J. Cerfolio, MD, Ayesha.

Mark I. Block, MD The Annals of Thoracic Surgery

Lobectomy Versus Limited Resection in T1N0 Lung Cancer

The Impact of New Technology on Cardiothoracic Surgical Practice

Domenico Galetta, MD, PhD, Lorenzo Spaggiari, MD, PhD

J. Alberto Lopez, MD The Annals of Thoracic Surgery

Presentation transcript:

Clinical Significance of Tumor-Infiltrating Lymphocytes in Lung Neoplasms Enrico Ruffini, MD, Sofia Asioli, MD, Pier Luigi Filosso, MD, Paraskevas Lyberis, MD, Maria Cristina Bruna, MD, Luigia Macrì, MD, Lorenzo Daniele, MD, Alberto Oliaro, MD The Annals of Thoracic Surgery Volume 87, Issue 2, Pages 365-372 (February 2009) DOI: 10.1016/j.athoracsur.2008.10.067 Copyright © 2009 The Society of Thoracic Surgeons Terms and Conditions

Fig 1 Survival according to the presence or absence of tumor-infiltrating lymphocytes (TIL) in total population of patients with lung neoplasms who underwent resection (p = 0.20). The Annals of Thoracic Surgery 2009 87, 365-372DOI: (10.1016/j.athoracsur.2008.10.067) Copyright © 2009 The Society of Thoracic Surgeons Terms and Conditions

Fig 2 Survival according to the presence or absence of tumor-infiltrating lymphocytes (TIL) in population of patients for lung squamous cell carcinoma who underwent resection (p = 0.03). The Annals of Thoracic Surgery 2009 87, 365-372DOI: (10.1016/j.athoracsur.2008.10.067) Copyright © 2009 The Society of Thoracic Surgeons Terms and Conditions

Fig 3 Survival according to the presence or absence of tumor-infiltrating lymphocytes (TIL) in population of patients with stage I lung squamous cell carcinoma who underwent resection (p = 0.03). The Annals of Thoracic Surgery 2009 87, 365-372DOI: (10.1016/j.athoracsur.2008.10.067) Copyright © 2009 The Society of Thoracic Surgeons Terms and Conditions

Fig 4 Survival according to the presence or absence of tumor-infiltrating lymphocytes (TIL) in population of patients with stage I lung adenocarcinoma who underwent resection (p = 0.63). The Annals of Thoracic Surgery 2009 87, 365-372DOI: (10.1016/j.athoracsur.2008.10.067) Copyright © 2009 The Society of Thoracic Surgeons Terms and Conditions